Terms: = Sarcomas AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Treatment
129 results:
1. Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
Pallocca M; Molineris I; Berrino E; Marcozzi B; Betti M; Levati L; D'Atri S; Menin C; Madonna G; Ghiorzo P; Bulgarelli J; Ferraresi V; Venesio T; Rodolfo M; Rivoltini L; Lanfrancone L; Ascierto PA; Mazzarella L; Pelicci PG; De Maria R; Ciliberto G; Medico E; Russo G
J Transl Med; 2024 Jan; 22(1):29. PubMed ID: 38184610
[TBL] [Abstract] [Full Text] [Related]
2. Receptor Tyrosine Kinase Inhibitors for the treatment of Recurrent and Unresectable Bone sarcomas.
Albarrán V; Villamayor ML; Chamorro J; Rosero DI; Pozas J; San Román M; Calvo JC; Pérez de Aguado P; Moreno J; Guerrero P; González C; García de Quevedo C; Álvarez-Ballesteros P; Vaz MÁ
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430263
[TBL] [Abstract] [Full Text] [Related]
3. A rapidly growing cutaneous malignant glomus tumor with a CCND3 mutation.
Kitz R; Leung O; Royer M
J Cutan Pathol; 2023 Feb; 50(2):113-117. PubMed ID: 36059094
[TBL] [Abstract] [Full Text] [Related]
4. Ripretinib in advanced gastrointestinal stromal tumors: an overview of current evidence and drug approval.
Goggin C; Stansfeld A; Mahalingam P; Thway K; Smith MJ; Huang P; Jones RL; Napolitano A
Future Oncol; 2022 Aug; 18(26):2967-2978. PubMed ID: 35880452
[TBL] [Abstract] [Full Text] [Related]
5. Targeting Podoplanin for the treatment of Osteosarcoma.
Takemoto A; Takagi S; Ukaji T; Gyobu N; Kakino M; Takami M; Kobayashi A; Lebel M; Kawaguchi T; Sugawara M; Tsuji-Takayama K; Ichihara K; Funauchi Y; Ae K; Matsumoto S; Sugiura Y; Takeuchi K; Noda T; Katayama R; Fujita N
Clin Cancer Res; 2022 Jun; 28(12):2633-2645. PubMed ID: 35381070
[TBL] [Abstract] [Full Text] [Related]
6. Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (pdgfr) Inhibitors for the treatment of Osteosarcoma.
Chen X; Liu L; Liu P; Chen Y; Lin D; Yan H; Yan Q; Wang Y; Qiu Y; Fang B; Huang H; Qian J; Zhao Y; Du Z; Zhang Q; Li X; Zheng X; Liu Z
J Med Chem; 2022 Apr; 65(7):5374-5391. PubMed ID: 35239349
[TBL] [Abstract] [Full Text] [Related]
7. Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma.
Safaric Tepes P; Segovia D; Jevtic S; Ramirez D; Lyons SK; Sordella R
Lab Invest; 2022 Sep; 102(9):1038-1049. PubMed ID: 34837064
[TBL] [Abstract] [Full Text] [Related]
8. [Surgical and interdisciplinary treatment of gastrointestinal stromal tumors].
Schmidt T; Ghadimi M; Fuchs HF; Bruns CJ
Chirurg; 2022 Jan; 93(1):27-33. PubMed ID: 34709443
[TBL] [Abstract] [Full Text] [Related]
9. Establishment and characterization of NCC-PLPS1-C1, a novel patient-derived cell line of pleomorphic liposarcoma.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Mar; 34(2):688-697. PubMed ID: 33205363
[TBL] [Abstract] [Full Text] [Related]
10. Establishment and characterization of NCC-MLPS1-C1: a novel patient-derived cell line of myxoid liposarcoma.
Noguchi R; Yoshimatsu Y; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Mar; 34(2):667-674. PubMed ID: 33146842
[TBL] [Abstract] [Full Text] [Related]
11. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma.
Chan JY; Lim JQ; Yeong J; Ravi V; Guan P; Boot A; Tay TKY; Selvarajan S; Md Nasir ND; Loh JH; Ong CK; Huang D; Tan J; Li Z; Ng CC; Tan TT; Masuzawa M; Sung KW; Farid M; Quek RHH; Tan NC; Teo MCC; Rozen SG; Tan P; Futreal A; Teh BT; Soo KC
J Clin Invest; 2020 Nov; 130(11):5833-5846. PubMed ID: 33016928
[TBL] [Abstract] [Full Text] [Related]
12. The role of novel fusion genes in human GIST cell lines derived from imatinib-resistant GIST patients: A therapeutic potential of fusion gene.
Cho WC; Shin YK; Na YS; Ryu MH; Ku JL; Kang YK
Biochem Biophys Res Commun; 2020 Aug; 529(3):699-706. PubMed ID: 32736695
[TBL] [Abstract] [Full Text] [Related]
13. Down-regulation of pdgfrβ suppresses invasion and migration in osteosarcoma cells by influencing epithelial-mesenchymal transition.
Xing S; Wang C; Tang H; Guo J; Liu X; Yi F; Liu G; Wu X
FEBS Open Bio; 2020 Sep; 10(9):1748-1757. PubMed ID: 32580247
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue sarcomas.
Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
[TBL] [Abstract] [Full Text] [Related]
15. Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium.
Harrison DJ; Gill JD; Roth ME; Zhang W; Teicher B; Erickson S; Gatto G; Kurmasheva RT; Houghton PJ; Smith MA; Kolb EA; Gorlick R
Pediatr Blood Cancer; 2020 Jun; 67(6):e28222. PubMed ID: 32207565
[TBL] [Abstract] [Full Text] [Related]
16. Novel Aspects of Genetics, Molecular Biology and Clinical Oncology of sarcomas.
Houfková K; Hatina J
Klin Onkol; 2020; 33(1):66-78. PubMed ID: 32075391
[TBL] [Abstract] [Full Text] [Related]
17. Signaling pathways in Rhabdomyosarcoma invasion and metastasis.
Ramadan F; Fahs A; Ghayad SE; Saab R
Cancer Metastasis Rev; 2020 Mar; 39(1):287-301. PubMed ID: 31989508
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathologic Correlation of Kaposi Sarcoma Involving the Ocular Adnexa: Immunophenotyping of Diagnostic and Therapeutic Targets.
Ulloa-Padilla JP; Ghassibi MP; Dubovy SR; Kerr DA
Ophthalmic Plast Reconstr Surg; 2020; 36(2):185-190. PubMed ID: 31743287
[TBL] [Abstract] [Full Text] [Related]
19. An update on current and future treatment options for chondrosarcoma.
MacDonald IJ; Lin CY; Kuo SJ; Su CM; Tang CH
Expert Rev Anticancer Ther; 2019 Sep; 19(9):773-786. PubMed ID: 31462102
[No Abstract] [Full Text] [Related]
20. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A
Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699
[TBL] [Abstract] [Full Text] [Related]
[Next]
